BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Merck Life Science Launches First GMP Compliant Manufacturing Line for Cell Culture Media in China

Merck Life Science is thrilled to announce the commencement of commercial production at our first Good Manufacturing Practice (GMP) compliant manuf...

July 16, 2024 | News

BioGeometry and Sanyou Bio Forge Strategic Partnership to Innovate Antibody Drug Discovery

BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that spe...

July 12, 2024 | News

Hinova Pharmaceuticals Secures FDA Fast Track Designation for HP518 in Treating AR+ Triple-Negative Breast Cancer

Hinova Pharmaceuticals a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food an...

July 08, 2024 | News

XPOVIO® Secures NMPA Approval for Treatment of R/R DLBCL in China, Expanding Its Indications

- Following its initial approval for the treatment of relapsed/refractory multiple myeloma (R/R MM), XPOVIO® has now received approval as a monoth...

July 08, 2024 | News

Pulnovo Medical Launches Global Multicenter Study for PADN Treatment in Pulmonary Hypertension at Lisbon's Hospital de Santa Marta

Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announc...

July 02, 2024 | News

HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...

July 02, 2024 | News

IASO Biotechnology Secures NMPA Approval for IND Application of RD118 CAR-T Therapy Targeting GPRC5D for Relapsed/Refractory Multiple Myeloma

IASO Biotechnology , a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody pr...

July 01, 2024 | News

Simcere Zaiming's Enlituo® Receives NMPA Approval for mCRC Treatment

Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group (2096.HK), announced that Enlituo® (generic name: cetu...

June 27, 2024 | News

Porton Advanced Integrates MaxCyte cGMP-Grade Electroporation System into Cell Therapy Platform

Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as ...

June 26, 2024 | News

FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment

U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...

June 25, 2024 | News

EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer

— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...

June 24, 2024 | News

Dizal's Golidocitinib Approved in China as First JAK1-Only Inhibitor for Relapsed or Refractory Peripheral T-Cell Lymphoma

Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational piv...

June 20, 2024 | News

YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China

YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...

June 19, 2024 | News

ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration

ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...

June 18, 2024 | News

Stay Connected